Malaria plagues nearly half the world's population. Since the war, researchers have been inching closer to a definitive cure for the disease. Last week it looked as if they just about had it—a new drug which, used with quinine, permanently cures 95% of all relapsing malaria cases. Still unnamed, it is identified as SN 13,274. The drug was developed at Columbia University, with U.S. Public Health Service aid, by a group of chemists headed by Dr. Robert C. Elderfield.
Relapsing malaria is difficult to cure because the tiny parasites that cause the disease lurk...
To continue reading:
or
Log-In